Personalis Inc stock is traded at $15.45, with a volume of 133,971. It is down -1.69% in the last 24 hours and down -1.31% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Previous Close:
$15.71
Open:
$15.60
24h Volume:
133,971
Relative Volume:
0.06
Market Cap:
$1.67B
Revenue:
$64.52M
Net Income/Loss:
-$95.55M
P/E Ratio:
-
EPS:
-$1.02
Net Cash Flow:
-$84.65M
1W Performance:
-3.17%
1M Performance:
-1.31%
6M Performance:
+142.85%
1Y Performance:
+105.66%
1-Day Range:
$15.42$15.69
1-Week Range:
$15.42$16.07
52-Week Range:
$4.96$18.89
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
650-752-1300Address
6600 DUMBARTON CIRCLE, FREMONT, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS